J3316 Injection., triptorelin x-ray 3.75 milligrams
J-Codes
Also known as: triptorelin XR, extended-release triptorelin, long-acting GnRH agonist
Triptorelin extended-release 3.75 milligram injection is a long-acting gonadotropin-releasing hormone agonist for prostate cancer and endometriosis.
Clinical Context
Indicated for advanced prostate cancer requiring sustained hormone suppression. Extended-release formulation allows quarterly dosing versus more frequent standard triptorelin. Used in endometriosis and precocious puberty.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.